HEADER SIGNALING PROTEIN 23-OCT-20 7KIE TITLE CRYSTAL STRUCTURE OF FGFR2 KINASE DOMAIN GATEKEEPER MUTANT V564F IN TITLE 2 COMPLEX WITH COVALENT COMPOUND 3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 461-768; COMPND 5 SYNONYM: FGFR-2,K-SAM,KGFR,KERATINOCYTE GROWTH FACTOR RECEPTOR; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR2, BEK, KGFR, KSAM; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FGFR KINASE DOMAIN, FGFR, FGFR2, FGFR3, KINASE INHIBITOR, COVALENT KEYWDS 2 INHIBITOR, GATEKEEPER MUTANT, RTK, SIGNALING PROTEIN, TUMOR GROWTH, KEYWDS 3 CHOLANGIOCARCINOMA EXPDTA X-RAY DIFFRACTION AUTHOR J.KE,A.S.WIBOWO,J.J.CARTER,N.A.LARSEN REVDAT 2 18-OCT-23 7KIE 1 REMARK REVDAT 1 10-FEB-21 7KIE 0 JRNL AUTH R.A.BRAWN,A.COOK,K.OMOTO,J.KE,C.KARR,F.COLOMBO, JRNL AUTH 2 M.VIRRANKOSKI,S.PRAJAPATI,D.REYNOLDS,D.M.BOLDUC,T.V.NGUYEN, JRNL AUTH 3 P.GEE,D.BORRELLI,B.CALEB,S.YAO,S.IRWIN,N.A.LARSEN, JRNL AUTH 4 A.SELVARAJ,X.ZHAO,S.IOANNIDIS JRNL TITL DISCOVERY OF AMINOPYRAZOLE DERIVATIVES AS POTENT INHIBITORS JRNL TITL 2 OF WILD-TYPE AND GATEKEEPER MUTANT FGFR2 AND 3. JRNL REF ACS MED.CHEM.LETT. V. 12 93 2021 JRNL REFN ISSN 1948-5875 JRNL PMID 33488969 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00517 REMARK 2 REMARK 2 RESOLUTION. 2.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28141 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1471 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.47 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.53 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2025 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.3360 REMARK 3 BIN FREE R VALUE SET COUNT : 106 REMARK 3 BIN FREE R VALUE : 0.3560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4663 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 104 REMARK 3 SOLVENT ATOMS : 165 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.58000 REMARK 3 B22 (A**2) : -0.43000 REMARK 3 B33 (A**2) : 1.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.389 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.242 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.192 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.125 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4896 ; 0.005 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6612 ; 1.370 ; 1.666 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 583 ; 6.976 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 248 ;34.193 ;22.500 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 881 ;17.695 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;20.322 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 605 ; 0.101 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3728 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 466 A 801 4 REMARK 3 1 B 466 B 801 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 2336 ; 0.470 ; 0.500 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2336 ; 6.120 ; 2.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7KIE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000252529. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X17B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92009 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 R CDTE 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29660 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.470 REMARK 200 RESOLUTION RANGE LOW (A) : 56.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.15200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 1.21500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3RI1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% W/V PEG 8000, 0.1M SODIUM CITRATE REMARK 280 PH 4.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 53.15000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.45500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 53.15000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.45500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 461 REMARK 465 GLY A 462 REMARK 465 VAL A 463 REMARK 465 SER A 464 REMARK 465 GLU A 465 REMARK 465 MET A 584 REMARK 465 GLU A 585 REMARK 465 TYR A 586 REMARK 465 SER A 587 REMARK 465 TYR A 588 REMARK 465 ASP A 589 REMARK 465 ILE A 590 REMARK 465 ASN A 591 REMARK 465 ARG A 592 REMARK 465 VAL A 593 REMARK 465 GLU A 767 REMARK 465 GLU A 768 REMARK 465 ALA B 461 REMARK 465 GLY B 462 REMARK 465 VAL B 463 REMARK 465 SER B 464 REMARK 465 GLU B 465 REMARK 465 MET B 584 REMARK 465 GLU B 585 REMARK 465 TYR B 586 REMARK 465 SER B 587 REMARK 465 TYR B 588 REMARK 465 ASP B 589 REMARK 465 ILE B 590 REMARK 465 ASN B 591 REMARK 465 ARG B 592 REMARK 465 VAL B 593 REMARK 465 GLU B 768 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 492 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 597 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 595 -9.72 -151.27 REMARK 500 ARG A 625 -9.97 82.94 REMARK 500 ASP A 626 47.49 -143.64 REMARK 500 ALA A 628 152.90 173.83 REMARK 500 ASP A 644 74.84 54.75 REMARK 500 ASN A 653 45.69 -98.59 REMARK 500 TYR A 657 -4.13 77.20 REMARK 500 ASN A 727 30.04 -86.16 REMARK 500 CYS B 491 -82.47 -108.33 REMARK 500 LYS B 509 -6.62 82.72 REMARK 500 GLU B 595 41.90 -105.92 REMARK 500 GLN B 597 148.00 -36.43 REMARK 500 ARG B 625 -9.45 80.70 REMARK 500 ASP B 644 65.65 66.42 REMARK 500 ASN B 653 61.29 -102.73 REMARK 500 TYR B 657 7.48 83.20 REMARK 500 ASN B 727 3.48 83.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 981 DISTANCE = 6.47 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7KIA RELATED DB: PDB REMARK 900 RELATED COVALENT COMPOUND DBREF 7KIE A 461 768 UNP P21802 FGFR2_HUMAN 461 768 DBREF 7KIE B 461 768 UNP P21802 FGFR2_HUMAN 461 768 SEQADV 7KIE PHE A 564 UNP P21802 VAL 564 ENGINEERED MUTATION SEQADV 7KIE PHE B 564 UNP P21802 VAL 564 ENGINEERED MUTATION SEQRES 1 A 308 ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO LYS SEQRES 2 A 308 TRP GLU PHE PRO ARG ASP LYS LEU THR LEU GLY LYS PRO SEQRES 3 A 308 LEU GLY GLU GLY CYS PHE GLY GLN VAL VAL MET ALA GLU SEQRES 4 A 308 ALA VAL GLY ILE ASP LYS ASP LYS PRO LYS GLU ALA VAL SEQRES 5 A 308 THR VAL ALA VAL LYS MET LEU LYS ASP ASP ALA THR GLU SEQRES 6 A 308 LYS ASP LEU SER ASP LEU VAL SER GLU MET GLU MET MET SEQRES 7 A 308 LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU LEU SEQRES 8 A 308 GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE PHE SEQRES 9 A 308 GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU ARG SEQRES 10 A 308 ALA ARG ARG PRO PRO GLY MET GLU TYR SER TYR ASP ILE SEQRES 11 A 308 ASN ARG VAL PRO GLU GLU GLN MET THR PHE LYS ASP LEU SEQRES 12 A 308 VAL SER CYS THR TYR GLN LEU ALA ARG GLY MET GLU TYR SEQRES 13 A 308 LEU ALA SER GLN LYS CYS ILE HIS ARG ASP LEU ALA ALA SEQRES 14 A 308 ARG ASN VAL LEU VAL THR GLU ASN ASN VAL MET LYS ILE SEQRES 15 A 308 ALA ASP PHE GLY LEU ALA ARG ASP ILE ASN ASN ILE ASP SEQRES 16 A 308 TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL LYS SEQRES 17 A 308 TRP MET ALA PRO GLU ALA LEU PHE ASP ARG VAL TYR THR SEQRES 18 A 308 HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 19 A 308 GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY ILE SEQRES 20 A 308 PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY HIS SEQRES 21 A 308 ARG MET ASP LYS PRO ALA ASN CYS THR ASN GLU LEU TYR SEQRES 22 A 308 MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER GLN SEQRES 23 A 308 ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP ARG SEQRES 24 A 308 ILE LEU THR LEU THR THR ASN GLU GLU SEQRES 1 B 308 ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO LYS SEQRES 2 B 308 TRP GLU PHE PRO ARG ASP LYS LEU THR LEU GLY LYS PRO SEQRES 3 B 308 LEU GLY GLU GLY CYS PHE GLY GLN VAL VAL MET ALA GLU SEQRES 4 B 308 ALA VAL GLY ILE ASP LYS ASP LYS PRO LYS GLU ALA VAL SEQRES 5 B 308 THR VAL ALA VAL LYS MET LEU LYS ASP ASP ALA THR GLU SEQRES 6 B 308 LYS ASP LEU SER ASP LEU VAL SER GLU MET GLU MET MET SEQRES 7 B 308 LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU LEU SEQRES 8 B 308 GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE PHE SEQRES 9 B 308 GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU ARG SEQRES 10 B 308 ALA ARG ARG PRO PRO GLY MET GLU TYR SER TYR ASP ILE SEQRES 11 B 308 ASN ARG VAL PRO GLU GLU GLN MET THR PHE LYS ASP LEU SEQRES 12 B 308 VAL SER CYS THR TYR GLN LEU ALA ARG GLY MET GLU TYR SEQRES 13 B 308 LEU ALA SER GLN LYS CYS ILE HIS ARG ASP LEU ALA ALA SEQRES 14 B 308 ARG ASN VAL LEU VAL THR GLU ASN ASN VAL MET LYS ILE SEQRES 15 B 308 ALA ASP PHE GLY LEU ALA ARG ASP ILE ASN ASN ILE ASP SEQRES 16 B 308 TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL LYS SEQRES 17 B 308 TRP MET ALA PRO GLU ALA LEU PHE ASP ARG VAL TYR THR SEQRES 18 B 308 HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU MET TRP SEQRES 19 B 308 GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY ILE SEQRES 20 B 308 PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY HIS SEQRES 21 B 308 ARG MET ASP LYS PRO ALA ASN CYS THR ASN GLU LEU TYR SEQRES 22 B 308 MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER GLN SEQRES 23 B 308 ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP ARG SEQRES 24 B 308 ILE LEU THR LEU THR THR ASN GLU GLU HET WF7 A 801 33 HET FLC A 802 13 HET GOL A 803 6 HET WF7 B 801 33 HET FLC B 802 13 HET GOL B 803 6 HETNAM WF7 N-{4-[(E)-2-{4-(4-METHYLPIPERAZIN-1-YL)-6-[(5-METHYL- HETNAM 2 WF7 1H-PYRAZOL-3-YL)AMINO]PYRIMIDIN-2- HETNAM 3 WF7 YL}ETHENYL]PHENYL}PROP-2-ENAMIDE HETNAM FLC CITRATE ANION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 WF7 2(C24 H28 N8 O) FORMUL 4 FLC 2(C6 H5 O7 3-) FORMUL 5 GOL 2(C3 H8 O3) FORMUL 9 HOH *165(H2 O) HELIX 1 AA1 PRO A 477 ASP A 479 5 3 HELIX 2 AA2 THR A 524 GLY A 542 1 19 HELIX 3 AA3 ASN A 571 ALA A 578 1 8 HELIX 4 AA4 THR A 599 GLN A 620 1 22 HELIX 5 AA5 ALA A 628 ARG A 630 5 3 HELIX 6 AA6 PRO A 666 MET A 670 5 5 HELIX 7 AA7 ALA A 671 ASP A 677 1 7 HELIX 8 AA8 THR A 681 THR A 698 1 18 HELIX 9 AA9 GLU A 711 GLY A 719 1 9 HELIX 10 AB1 THR A 729 TRP A 740 1 12 HELIX 11 AB2 VAL A 743 ARG A 747 5 5 HELIX 12 AB3 THR A 749 ASN A 766 1 18 HELIX 13 AB4 PRO B 477 ASP B 479 5 3 HELIX 14 AB5 THR B 524 GLY B 542 1 19 HELIX 15 AB6 ASN B 571 ALA B 578 1 8 HELIX 16 AB7 THR B 599 GLN B 620 1 22 HELIX 17 AB8 ALA B 628 ARG B 630 5 3 HELIX 18 AB9 ASP B 644 ALA B 648 5 5 HELIX 19 AC1 PRO B 666 MET B 670 5 5 HELIX 20 AC2 ALA B 671 ASP B 677 1 7 HELIX 21 AC3 THR B 681 THR B 698 1 18 HELIX 22 AC4 PRO B 708 GLU B 710 5 3 HELIX 23 AC5 GLU B 711 GLU B 718 1 8 HELIX 24 AC6 THR B 729 TRP B 740 1 12 HELIX 25 AC7 VAL B 743 ARG B 747 5 5 HELIX 26 AC8 THR B 749 ASN B 766 1 18 SHEET 1 AA1 5 LEU A 481 GLY A 488 0 SHEET 2 AA1 5 GLN A 494 VAL A 501 -1 O MET A 497 N GLY A 484 SHEET 3 AA1 5 ALA A 511 MET A 518 -1 O VAL A 516 N VAL A 496 SHEET 4 AA1 5 TYR A 561 GLU A 565 -1 O PHE A 564 N ALA A 515 SHEET 5 AA1 5 LEU A 550 CYS A 554 -1 N GLY A 552 O ILE A 563 SHEET 1 AA2 2 CYS A 622 ILE A 623 0 SHEET 2 AA2 2 ARG A 649 ASP A 650 -1 O ARG A 649 N ILE A 623 SHEET 1 AA3 2 VAL A 632 VAL A 634 0 SHEET 2 AA3 2 MET A 640 ILE A 642 -1 O LYS A 641 N LEU A 633 SHEET 1 AA4 5 LEU B 481 GLY B 488 0 SHEET 2 AA4 5 GLN B 494 VAL B 501 -1 O GLU B 499 N THR B 482 SHEET 3 AA4 5 ALA B 511 MET B 518 -1 O VAL B 516 N VAL B 496 SHEET 4 AA4 5 TYR B 561 GLU B 565 -1 O PHE B 564 N ALA B 515 SHEET 5 AA4 5 LEU B 550 CYS B 554 -1 N LEU B 551 O ILE B 563 SHEET 1 AA5 2 CYS B 622 ILE B 623 0 SHEET 2 AA5 2 ARG B 649 ASP B 650 -1 O ARG B 649 N ILE B 623 SHEET 1 AA6 2 VAL B 632 VAL B 634 0 SHEET 2 AA6 2 MET B 640 ILE B 642 -1 O LYS B 641 N LEU B 633 LINK SG CYS A 491 C22 WF7 A 801 1555 1555 1.63 LINK SG CYS B 491 C22 WF7 B 801 1555 1555 1.61 CRYST1 106.300 116.910 64.670 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009407 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008554 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015463 0.00000 MTRIX1 1 1.000000 0.000000 0.000000 0.00000 1 MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 1 0.000000 0.000000 1.000000 0.00000 1 MTRIX1 2 -0.061755 -0.695793 0.715583 44.95805 1 MTRIX2 2 -0.682911 -0.493401 -0.538691 63.65274 1 MTRIX3 2 0.727886 -0.521947 -0.444695 2.03231 1